Advertisement

Drug Makers Raise Prices on 500 Prescription Drugs

0

AbbVie, Bristol Myers Squibb, GlaxoSmithKline, and Pfizer among companies raising their prices by a median of 4.6 percent

Mindfulness Training Does Not Reduce Migraine Frequency

0

However, mindfulness-based stress reduction improves various measures, including disability and quality of life

Sixty-Day Outcomes Examined for Hospitalized COVID-19 Patients

Some Hospitalized Heart Patients Report Frequent Nightmares

0

Frequent nightmares associated with depression, anxiety, insomnia but not cardiovascular medications, sleep-disordered breathing

Organized Sports May Help Boys Control Behavior

Child Physical Abuse Encounters Declined During COVID-19

0

Declines occurred during period when total volume of encounters was also lower; severity of encounters unchanged versus previous years

Mental Health Consequences of COVID-19 ID’d Across Populations

0

Health care workers have higher prevalence of insomnia; however, mental health problems seen across countries, gender

U.S. Health Care Spending Increased 4.6 Percent in 2019

0

Growth rate similar to that experienced in 2018 and consistent with growth rate since 2016

Odds of Anxiety, Depression, ADHD Up With Congenital Heart Disease

0

Youth with CHD have increased odds of anxiety and/or depression, ADHD, regardless of CHD severity

Autistic Traits ID’d in Carriers of CNVs Linked to Autism

0

54 percent of carriers of certain copy number variants have elevated levels of autistic traits

Outcomes Vary for Depression Collaborative Care Programs

Suicide Risk Higher Among Patients With Parkinson Disease

0

Increased risk not fully explained by higher rates of mental disorders

ASA: Sustained Decrease Seen in Prescription Opioid Abuse in U.S.

Gaps Found in Opioid Use Disorder Treatment During Pandemic

0

Percentage of patients receiving at least one urine test lower in March through May of 2020 versus 2019